Last reviewed · How we verify

NCT05416086

iCLAS™ Cryoablation System Post-Market Clinical Follow-up (PMCF) Study

Terminated NA Last updated 13 April 2026
What this trial tests

NA trial testing cryoablation procedure using the iCLAS Cryoablation System in Atrial Fibrillation in 91 participants. Terminated before completion.

Timeline
3 September 2021
Primary endpoint
28 January 2025
28 January 2025

Quick facts

Lead sponsorAdagio Medical
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment91
Start date3 September 2021
Primary completion28 January 2025
Estimated completion28 January 2025
Sites4 locations across Belgium, Netherlands, Germany

Drugs / interventions tested

Conditions studied

Sponsor

Adagio Medical — full company profile →

Who can join

18 and older, any sex, with Atrial Fibrillation or Atrial Flutter. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A prospective, single-arm, multi-center study designed to collect real world safety and performance data of the Adagio Medical iCLAS Cryoablation System in the treatment of drug refractory, recurrent, symptomatic, Paroxysmal Atrial Fibrillation (PAF), Persistent Atrial Fibrillation (PsAF), and Atrial Flutter (AFL).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Durability of Ultra-Low Temperature Cryoablation Lesions in Atrial Fibrillation: Insights From Repeat Ablation Procedures.
    Abeln BGS, Addeo L, De Potter T, Boersma LVA. · · 2025 · cited 1× · PMID 40150915 · DOI 10.1111/jce.16665

Verify or expand the search:

Other recruiting trials for Atrial Fibrillation

Currently open trials in the same condition.

Other Adagio Medical trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05416086.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing